Cyclacel pharma reports quarterly loss per share of $1.48

Cyclacel pharmaceuticals reports first quarter 2020 financial results.cyclacel pharmaceuticals inc - as of march 31, 2020, cash and cash equivalents totaled $8.9 million, compared to $11.9 million as of december 31, 2019.cyclacel pharmaceuticals inc - qtrly loss per share $1.48.cyclacel pharmaceuticals-sees cash resources as of march 31, with net proceeds from april financing will fund currently planned programs through 2022.
CYCC Ratings Summary
CYCC Quant Ranking